Matthew Vander Heiden

Wolfe Professor & Director, Koch Institute
Department
David H Koch Institute for Integrative Cancer Res
Technology Areas
Therapeutics: Small Molecules, Cell Based Therapy / Drug Discovery and Research Tools: Cell Interrogation
Impact Areas
Healthy Living, Uncharted Frontiers

Technologies

Nucleotide Depletion as Differentiation Therapy in the Treatment of Cancer

Technology / Case number: #21131J
Matthew Vander Heiden / Peggy Hsu / David Sykes / Frances Diehl
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Methods and Compositions for Increasing Sensitivity of Cancer Cells to Glutaminase Inhibitors and Applications to Cancer Therapy

Technology / Case number: #19305
Matthew Vander Heiden / Dan Gui / Alexander Muir / Laura Danai
Technology Areas: Therapeutics
Impact Areas: Healthy Living, Uncharted Frontiers
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up